[Nle27]-GRF (1-29) amide (human)

[Nle27]-GRF (1-29) amide (human)

[Nle27]-GRF (1-29) amide (human)

[Nle27]-GRF (1-29) amide (human)

[Nle27]-GRF (1-29) amide (human)

[Nle27]-GRF (1-29) amide (human) is a high-purity synthetic peptide analog of human growth hormone-releasing hormone (GHRH), featuring a norleucine (Nle) substitution at position 27 to enhance metabolic stability and reduce oxidation sensitivity. This 29-amino acid peptide functions as a potent and specific agonist for GHRH receptors, stimulating growth hormone secretion from pituitary somatotrophs with improved in vivo stability compared to native GHRH. With HPLC-verified purity and comprehensive analytical documentation, it provides researchers with a reliable tool for studying growth axis regulation, endocrine physiology, and metabolic processes in both in vitro and in vivo models. The enhanced stability profile makes it particularly valuable for prolonged studies requiring sustained growth hormone stimulation.


TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
[Nle27]-GRF (1-29) amide (human) 
CAS NO.
/
Appearance
White to off-white lyophilized powder
Molecular Formula
C150H247N44O42
Molecular Weight
 3338.91g/mol 
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water, acetic acid (0.1%), and DMSO; may require gentle vortexing for complete dissolution

Endotoxin< 1.0 EU/mg
Biological Activity
Growth hormone-releasing hormone (GHRH) agonist; stimulates growth hormone secretion from anterior pituitary somatotrophs via activation of GHRH receptor.
Storage Conditions
Store at -20°C or below, protected from light and moisture. After reconstitution, aliquot and store at -20°C.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

[Nle27]-GRF (1-29) amide (human) binds with high affinity to GHRH receptors on pituitary somatotroph cells, activating G-protein coupled signaling pathways. The norleucine substitution at position 27 enhances peptide stability by reducing methionine oxidation, while maintaining full receptor binding affinity. This binding stimulates adenylate cyclase activity, increasing intracellular cAMP levels and activating protein kinase A (PKA). The downstream effects include phosphorylation of transcription factors (such as CREB), enhanced growth hormone gene expression, and stimulation of growth hormone synthesis and secretion. The C-terminal amidation further enhances receptor binding and peptide stability, resulting in prolonged biological activity compared to native GHRH fragments.


2.PRODUCT INDICATIONS


Endocrine Research: Investigation of growth hormone regulation, pituitary function, and growth axis signaling with enhanced peptide stability

Metabolic Studies: Research on growth hormone's role in metabolism, body composition, and energy homeostasis using stable peptide analogs
Drug Discovery: Screening for GHRH receptor agonists with improved pharmacokinetic properties for therapeutic applications
Receptor Pharmacology: Study of GHRH receptor binding kinetics, signal transduction, and structure-activity relationships

Preclinical Studies: Evaluation of growth-promoting effects and endocrine system modulation in animal models requiring sustained peptide activity

Stability Research: Comparative studies on peptide stability, oxidation resistance, and metabolic half-life


3.CLINICAL EFFICACY OF PRODUCT

Enhanced Stability Profile: Norleucine substitution at position 27 significantly improves metabolic stability and reduces oxidation compared to native GHRH sequences
Validated Bioactivity: Demonstrated potent stimulation of growth hormone secretion in pituitary cells and in vivo models with prolonged activity
High Purity: ≥95% by RP-HPLC with mass spectrometry confirmation of sequence and C-terminal amidation
Improved Pharmacokinetics: Extended half-life and sustained biological effects compared to native GHRH (1-29) fragments
Research Reproducibility: Consistent performance in growth hormone release assays, receptor binding studies, and animal experiments
Quality Assurance: Produced under controlled conditions with low endotoxin levels for research applications
Documentation: Each batch includes Certificate of Analysis with purity, mass spec, and biological activity data


4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.